Bibliography
- FINDLING RL, REED MD, BLUMER JL: The pharmacol-ogical treatment of depression in children and adoles-cents. Paediatric Drugs (1999) 1:161–182.
- MELTZER HY, RABINOWITZ J, LEE MA et al: Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. Am. J. Psychiatry (1997) 154:475–482.
- KEEPERS GA, CLAPPISON VJ, CASEY DE: Initial anticho-linergic prophylaxis for neuroleptic-induced extrapy-ramidal syndromes. Arch. Gen. Psychiatry (1983) 40:1113–1117.
- CHANG KD, KETTER TA: Special issues in the treatmentof paediatric bipolar disorder. Exp. Opin. Pharmacother. (2001) 2(4):613–622.
- POSEY DJ, MCDOUGLE CJ: Ph armaco ther ap eutic management of autism. Exp. Opin. Pharmacother. (2001) 2 (4):587–600.
- MCDOUGLE CJ, SCAHILL L, MCCRACKEN JT et al.: Research Units on Pediatric Psychopharmacology (RUPP) Autism Network: background and rationale for an initial controlled study of risperidone. Child Adolesc. Psychiatric Clinics N America (2000) 9:201–224.
- FINDLING RL, GRACIOUS BL, MCNAMARA NK, CALABRESE JR: The rationale, design and progress of two novel maintenance treatment studies in pediatric bipolarity. Acta Neuropsychiatrica (2000) 12:136–138.
- THE MTA COOPERATIVE GROUP: A 14-monthrandomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen. Psychiatry (1999) 56:1073–1086.